Cleared Special

K220398 - Aristotle 14 Guidewire (FDA 510(k) Clearance)

Also includes:
Aristotle 18 Guidewire Aristotle 24 Guidewire Volo 14 Guidewire Zoom Wire 14 Guidewire

Class II Neurology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2023
Decision
392d
Days
Class 2
Risk

K220398 is an FDA 510(k) clearance for the Aristotle 14 Guidewire. Classified as Guide, Wire, Catheter, Neurovasculature (product code MOF), Class II - Special Controls.

Submitted by Scientia Vascular, LLC (West Valley City, US). The FDA issued a Cleared decision on March 10, 2023 after a review of 392 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1330 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Elevated predicate reliance profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Scientia Vascular, LLC devices

Submission Details

510(k) Number K220398 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 11, 2022
Decision Date March 10, 2023
Days to Decision 392 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
244d slower than avg
Panel avg: 148d · This submission: 392d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MOF Guide, Wire, Catheter, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - MOF Guide, Wire, Catheter, Neurovasculature

All 39
Devices cleared under the same product code (MOF) and FDA review panel - the closest regulatory comparables to K220398.
Aristotle 14 Guidewire
K253579 · Scientia Vascular, Inc. · Apr 2026
Zenith Micro Guidewire
K252317 · Suzhou Zenith Vascular SciTech Limited · Apr 2026
Willow 24 Guidewire
K260537 · Arbor Endovascular, LLC · Mar 2026
DCwire Micro-guidewire
K252122 · Shanghai Achieva Medical Suzhou Co., Ltd. · Mar 2026
Willow 18 Guidewire
K260130 · Arbor Endovascular, LLC · Feb 2026
CHIKAI Nexus petit
K252011 · Asahi Intecc Co., Ltd. · Feb 2026